Deleterious role of TNF-α in retinal ischemia-reperfusion injury

被引:65
作者
Berger, Samuel [1 ]
Savitz, Sean I. [2 ]
Nijhawan, Sheetal [1 ]
Singh, Manjeet [1 ]
David, Joel [1 ]
Rosenbaum, Pearl S. [3 ,4 ]
Rosenbaum, Daniel M. [1 ]
机构
[1] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA
[2] Univ Texas Houston, Sch Med, Dept Neurol, Houston, TX USA
[3] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Bronx Lebanon Hosp Ctr, Dept Ophthalmol, Bronx, NY 10467 USA
关键词
D O I
10.1167/iovs.07-0817
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Tumor necrosis factor (TNF)-alpha is a mediator of neuronal cell death and survival in ischemia-reperfusion injury. This study was conducted to further elucidate the role of TNF-alpha and its receptor in an in vivo model of retinal ischemia reperfusion injury by investigating its effects on retinal histopathology and function. METHODS. Retinal ischemia-reperfusion injury was performed on p55 and p75 knockout (KO) mice and Sprague-Dawley rats using the high intraocular pressure method. The temporal expression of TNF-alpha was ascertained with immunohistochemical staining. Separate rats received intravitreal recombinant TNF-alpha or neutralizing antibody before or after ischemia. TUNEL labeling was performed to assess for cell death, and electroretinography was performed to assess function. RESULTS. TNF-alpha expression peaked at 12 to 24 hours after ischemia-reperfusion injury. TUNEL staining was diminished after intravitreal TNF-alpha antibody. Both transgenic KOs demonstrated significantly less functional impairment. Rats receiving recombinant TNF-alpha 48 hours after ischemia showed exaggerated functional impairment. Animals treated with TNF-alpha antibody before ischemia displayed significant functional improvement. CONCLUSIONS. TNF-alpha plays a largely deleterious role in ischemia -reperfusion injury in an in vivo model of retinal injury. Direct neutralization of this cytokine partially preserves retinal function. The diverse characteristics of TNF-alpha are attributed in part to the timing of its expression after injury. TNF-alpha receptor expression and function, along with combination treatments targeting death receptor-mediated apoptosis, should be further explored to develop neuroprotective therapeutic strategies for acute retinal ischemic disorders.
引用
收藏
页码:3605 / 3610
页数:6
相关论文
共 29 条
[11]   Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury [J].
Lavine, SD ;
Hofman, FM ;
Zlokovic, BV .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (01) :52-58
[12]   Role of tumor necrosis factor-α in neuronal and glial apoptosis after spinal cord injury [J].
Lee, YB ;
Yune, TY ;
Baik, SY ;
Shin, YH ;
Du, S ;
Rhim, H ;
Lee, EB ;
Kim, YC ;
Shin, ML ;
Markelonis, GJ ;
Oh, TH .
EXPERIMENTAL NEUROLOGY, 2000, 166 (01) :190-195
[13]   Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation -: Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-κB pathway [J].
Marchetti, L ;
Klein, M ;
Schlett, K ;
Pfizenmaier, K ;
Eisel, ULM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (31) :32869-32881
[14]   Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke [J].
Martin-Villalba, A ;
Hahne, M ;
Kleber, S ;
Vogel, J ;
Falk, W ;
Schenkel, J ;
Krammer, PH .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (07) :679-686
[15]   Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis [J].
Murphy, CC ;
Greiner, K ;
Plskova, J ;
Duncan, L ;
Frost, A ;
Isaacs, JD ;
Rebello, P ;
Waldmann, H ;
Hale, G ;
Forrester, JV ;
Dick, AD .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (06) :845-851
[16]  
NITATORI T, 1995, J NEUROSCI, V15, P1001
[17]   Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid [J].
Rosenbaum, DM ;
Rosenbaum, PS ;
Gupta, A ;
Michaelson, MD ;
Hall, DH ;
Kessler, JA .
VISION RESEARCH, 1997, 37 (24) :3445-3451
[18]  
Rosenbaum DM, 1998, INVEST OPHTH VIS SCI, V39, P2132
[19]   TRAF2-MEDIATED ACTIVATION OF NF-KAPPA-B BY TNF RECEPTOR-2 AND CD40 [J].
ROTHE, M ;
SARMA, V ;
DIXIT, VW ;
GOEDDEL, DV .
SCIENCE, 1995, 269 (5229) :1424-1427
[20]   Evolution of cerebral tumor necrosis factor-α production during human ischemic stroke [J].
Sairanen, T ;
Carpén, O ;
Karjalainen-Lindsberg, ML ;
Paetau, A ;
Turpeinen, U ;
Kaste, M ;
Lindsberg, PJ .
STROKE, 2001, 32 (08) :1750-1757